Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 3, 2000

View Archived Issues

Research links autoantibodies to the symptoms of Sjogren's syndrome

New findings on an old drug: metformin

Possible connection between intestinal bacteria and autism revealed

Amiloride fails to show benefit in cystic fibrosis trial

Magainin receives patent for novel obesity compound

New technology may improve safety in testing of adenovirus-based gene therapies

Licensing opportunity from NIH: methods of gene targeting

Adeno-associated virus vector available for licensing from NIH

Licensing opportunity from NIH: AAV4 and its use for gene delivery

NIH offers apoptosis-inducing gene product for licensing

Licensing opportunity from NIH: replication-deficient retroviral vectors

Overexpression of UCP-3 results in reduced tissue mass in mice

Inconclusive results obtained with desferrioxamine in multiple sclerosis trial

Roche seeks approval of Tamiflu in Japan

Bayer's Cipro recommended for approval in treating anthrax exposure

Acadia granted phase I SBIR award for neuropsychiatric research

Concerta approved by FDA, licensed worldwide by Alza

Bavarian Nordic initiates phase I/II trial of metastatic malignant melanoma treatment

New compounds under development at AHP for treatment of inflammatory and autoimmune diseases

JNK protein kinase inhibitors under study at Roche

New selective dopamine D4 receptor antagonists useful for psychosis and schizophrenia

Antibacterial agents under development at British Biotech

New compounds interacting with 5-HT1A receptors useful for depression, etc.

New polypeptides useful for Chlamydia infection

New human lymphocytic membrane proteins under study at Incyte

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...